Thermo Fisher Scientific will acquire chromatography system manufacturer Dionex Corporation for $2.1 billion.
The maker of laboratory and diagnostic equipment will pay Dionex shareholders $118.50 per share in cash, a 21 percent premium to the stock’s closing price on Dec. 10. However, at least one shareholder has sued to block the deal, alleging that the price is too low.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
